Celebrating the launch of TMC207/R207910

Friday, February 01th, 2013 by hinrich

Celebrating the approval of Sirturo

With the approval of TMC207/R207910 I have for the first time in my career at Janssen seen a compound become available to patients where I have made some contributions to. It is frustrating to see how much effort is put into helping move drug discovery projects ahead and how frequently programs need to be stopped for various reasons.

On a positive note, this compound did make it. It provides hope for people suffering from MDR-TB. I do keep my fingers crossed that it will continue to do so and that side-effects that may appear will be manageable. Therefore I am looking forward to a small celebration that we will have close to Brussel next week.

Posted in Tuberculosis